Opus Genetics (IRD) EBITDA

Annual EBITDA

-$9.97 M
-$28.18 M-154.72%

December 1, 2023

Summary

Performance

1-Year Change

-154.72%

3-Year Change

+43.89%

5-Year Change

-109.54%

15-Year Change

-109.54%

IRD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.36%
IRD annual EBITDA is higher than 64.36% of companies in Healthcare sector

High & Low

All-time High

$18.22 M
IRD annual EBITDA is currently -154.72% below its historical high of $18.22 million

3-Year Low

-$56.69 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
IRD previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Mar 7, 2025
IRD next annual earnings announcement is scheduled for Mar 7, 2025

OtherIRDprofitabilitymetrics:

Annual Revenue

$19.05 M
IRD annual revenue is $19.05 million

Annual Net Income

-$9.99 M
IRD annual net profit is -$9.99 million

Annual EBIT

-$9.97 M
IRD annual earnings before interest & taxes is -$9.97 million

Annual EPS

-$0.46
IRD annual earnings per share is -$0.46

Quarterly EBITDA

-$7.53 M
+$802.00 K+9.63%

September 1, 2024

Summary

Performance

3-Month Change

+9.63%

1-Year Change

+2.36%

3-Year Change

-19.27%

5-Year Change

-19.27%

IRD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.47%
IRD quarterly EBITDA is higher than 40.47% of companies in Healthcare sector

High & Low

All-time High

$34.26 M
IRD quarterly EBITDA is currently -121.97% below its historical high of $34.26 million

3-Year Low

-$8.33 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
IRD previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
IRD next earnings announcement is scheduled for Mar 7, 2025

OtherIRDprofitabilitymetrics:

Quarterly Revenue

$3.87 M
IRD quarterly revenue is $3.87 million

Quarterly Net Income

-$7.53 M
IRD quarterly net profit is -$7.53 million

Quarterly EBIT

-$7.53 M
IRD quarterly earnings before interest & taxes is -$7.53 million

Quarterly EPS

-$0.29
IRD quarterly earnings per share is -$0.29

TTM EBITDA

-$29.68 M
-$14.43 M-94.60%

September 1, 2024

Summary

Performance

3-Month Change

-94.6%

1-Year Change

-141.06%

3-Year Change

+47.64%

5-Year Change

+47.64%

IRD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.98%
IRD TTM EBITDA is higher than 41.98% of companies in Healthcare sector

High & Low

All-time High

$29.64 M
IRD TTM EBITDA is currently -200.14% below its historical high of $29.64 million

3-Year Low

-$56.69 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
IRD previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
IRD next earnings announcement is scheduled for Mar 7, 2025

OtherIRDprofitabilitymetrics:

TTM Revenue

$8.38 M
IRD TTM revenue is $8.38 million

TTM Net Income

-$27.19 M
IRD TTM net profit is -$27.19 million

TTM EBIT

-$29.69 M
IRD TTM earnings before interest & taxes is -$29.69 million

TTM EPS

-$1.09
IRD TTM earnings per share is -$1.09

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$9.97 M
IRD annual EBITDA is -$9.97 million

Annual Net Income

-$9.99 M
IRD annual net profit is -$9.99 million

Annual Interest Expense

$0.00
IRD annual interest expense is $0.00

Annual Income Tax

$12.00 K
IRD annual income tax is $12.00 thousand

Annual D&A

$6000.00
IRD annual depreciation & amortization is $6000.00

IRD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-154.7%+2.4%-141.1%
3 y3 years+43.9%-19.3%+47.6%
5 y5 years-109.5%-19.3%+47.6%

IRD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-154.7%+82.4%-122.0%+9.6%-200.1%+47.6%
5 y5-year-154.7%+82.4%-122.0%+80.7%-200.1%+53.4%
alltimeall time-154.7%+82.4%-122.0%+80.7%-200.1%+53.4%

Opus Genetics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$7.53 M(-9.6%)
-$29.68 M(+94.6%)
Jun 2024
-
-$8.33 M(+8.0%)
-$15.25 M(+23.9%)
Mar 2024
-
-$7.71 M(+25.9%)
-$12.31 M(+14.7%)
Dec 2023
-$9.97 M(-154.7%)
-$6.12 M(-188.7%)
-$10.74 M(-136.2%)
Sep 2023
-
$6.90 M(-228.1%)
$29.64 M(+62.8%)
Jun 2023
-
-$5.39 M(-12.1%)
$18.21 M(-2.5%)
Mar 2023
-
-$6.13 M(-117.9%)
$18.68 M(+2.5%)
Dec 2022
$18.22 M
$34.26 M(-856.2%)
$18.22 M(-181.5%)
Sep 2022
-
-$4.53 M(-8.0%)
-$22.35 M(+1.4%)
Jun 2022
-
-$4.92 M(-25.3%)
-$22.05 M(-9.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$6.59 M(+4.4%)
-$24.26 M(-57.2%)
Dec 2021
-$56.69 M(+219.1%)
-$6.31 M(+49.2%)
-$56.69 M(-10.9%)
Sep 2021
-
-$4.23 M(-40.7%)
-$63.63 M(+5.2%)
Jun 2021
-
-$7.13 M(-81.7%)
-$60.47 M(+11.5%)
Mar 2021
-
-$39.01 M(+194.3%)
-$54.25 M(+205.4%)
Dec 2020
-$17.77 M(+273.4%)
-$13.25 M(+1141.0%)
-$17.77 M(+293.8%)
Sep 2020
-
-$1.07 M(+16.8%)
-$4.51 M(+31.0%)
Jun 2020
-
-$914.00 K(-63.9%)
-$3.44 M(+36.1%)
Mar 2020
-
-$2.53 M
-$2.53 M
Dec 2019
-$4.76 M
-
-

FAQ

  • What is Opus Genetics annual EBITDA?
  • What is the all time high annual EBITDA for Opus Genetics?
  • What is Opus Genetics annual EBITDA year-on-year change?
  • What is Opus Genetics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Opus Genetics?
  • What is Opus Genetics quarterly EBITDA year-on-year change?
  • What is Opus Genetics TTM EBITDA?
  • What is the all time high TTM EBITDA for Opus Genetics?
  • What is Opus Genetics TTM EBITDA year-on-year change?

What is Opus Genetics annual EBITDA?

The current annual EBITDA of IRD is -$9.97 M

What is the all time high annual EBITDA for Opus Genetics?

Opus Genetics all-time high annual EBITDA is $18.22 M

What is Opus Genetics annual EBITDA year-on-year change?

Over the past year, IRD annual EBITDA has changed by -$28.18 M (-154.72%)

What is Opus Genetics quarterly EBITDA?

The current quarterly EBITDA of IRD is -$7.53 M

What is the all time high quarterly EBITDA for Opus Genetics?

Opus Genetics all-time high quarterly EBITDA is $34.26 M

What is Opus Genetics quarterly EBITDA year-on-year change?

Over the past year, IRD quarterly EBITDA has changed by +$182.00 K (+2.36%)

What is Opus Genetics TTM EBITDA?

The current TTM EBITDA of IRD is -$29.68 M

What is the all time high TTM EBITDA for Opus Genetics?

Opus Genetics all-time high TTM EBITDA is $29.64 M

What is Opus Genetics TTM EBITDA year-on-year change?

Over the past year, IRD TTM EBITDA has changed by -$17.37 M (-141.06%)